Celiac disease seropositivity in Saharawi children: a follow-up and family study.
BACKGROUND
Celiac disease (CD) is a common disease in the Saharawi population of Arab-Berber origin. Saharawi patients with CD and their families were invited to participate in a follow-up study aimed at checking the CD serology status in patients being treated with the gluten-free diet (GFD) and investigating the prevalence of CD in first-degree relatives.


METHODS
We investigated 975 subjects (62.8% females and 37.2% males, age range 0.7 to 75.4 years, median age 13.4 years) belonging to 212 families, by determining the serum immunoglobulin A anti-transglutaminase and anti-endomysial antibody levels. Thirty-two first-degree relatives were already receiving GFD when tested.


RESULTS
Overall, 42.2% of the 244 treated subjects with CD showed a borderline/positive anti-transglutaminase determination, and 36.6% were also anti-endomysial positive. The serologic family screening detected 33 previously undiagnosed CD cases. The 65 affected first-degree relatives were sibling (42), mother (12), son/daughter (7), and father (4). The overall prevalence of CD among first-degree relatives was 65 of 763 (8.5%, 95% confidence interval 6.5-10.5). Based on our previous estimate of CD prevalence in the pediatric Saharawi population (5.6%), the sibling relative risk was 1.5.


CONCLUSIONS
The risk of CD in the Saharawis is only modestly increased in first-degree relatives compared with the general population, probably because of the higher frequency of CD predisposing genes in the general population. Saharawi patients with CD receiving GFD showed poor adherence to the treatment, which could contribute to residual CD-related morbidity and mortality.
Teresi
Saverio
S
Analysis Laboratory, G Di Cristina Children's Hospital, Palermo, Spain.
Crapisi
Mimì
M
Vallejo
Maria Dolores Cantarero
MD
Castellaneta
Stefania Paola
SP
Francavilla
Ruggiero
R
Iacono
Giuseppe
G
Ravelli
Alberto
A
Menegazzi
Patrizia
P
Louali
Mahana
M
Catassi
Carlo
C
D000293:Adolescent; D000328:Adult; D000352:Africa, Northern / Q000453:epidemiology; D000368:Aged; D018912:Arabs; D001323:Autoantibodies / Q000097:blood*; D002446:Celiac Disease / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D055050:Diet, Gluten-Free; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007223:Infant; D008297:Male; D008875:Middle Aged; D018485:Muscle Fibers, Skeletal / Q000276:immunology; D012307:Risk Factors; D012698:Serologic Tests; D011503:Transglutaminases / Q000235:genetics* / Q000276:immunology; D055815:Young Adult
D001323:Autoantibodies; D007070:Immunoglobulin A; D011503:Transglutaminases